Fell Audio’s designs are crafted by a hi-fi manufacturing partner and backed by a five-year warranty. The range, styled on a ...

The Fell Disc CD player sells for £499, and has a slot-loading mechanism and features an ESS Sabre ES9018 DAC. The player is ...

There's a new hi-fi brand in town. Fell Audio is a Cumbria-based, family-owned business backed by the 50-year-old specialist retailer, Peter Tyson, and aims to 'disrupt' the market by offering ...

刻录技术是指将数据信息通过激光束烧录到光盘介质上，形成可读写的光盘。不同的刻录技术产生的空隙大小不同，这些空隙对于光盘的读写速度和存储容量都有一定的影响。 A. CD-R（一次性可写入光盘）：CD-R是一种一次性可写入光盘，其刻录技术产生的空隙相对较大。这是因为CD-R的刻录过程需要在光盘表面形成凹坑，这些凹坑之间的空隙较大，以便激光能够准确地读取数据。

In terms of controls, the slot-loading R-CD100 offers an eject button alongside a power LED housed at the front of the unit. The new player is compatible with CD-DA, CD-R and CD-RW discs and features ...

The new player is compatible with CD-DA, CD-R and CD-RW discs and features a USB-C connection at the rear. Ruark is on a mighty hot streak at the moment and continues to impress us with products ...

At $12,000, the new Marantz SACD 10 is the best CD/SACD player the company has ever made and it weighs 73 lbs. The SACD 10 is Marantz’s newest CD/SACD player and the successor to the SA-10 ($7,499), ...

The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than cutting costs. Chris Hughes is a Bloomberg Opinion columnist covering ...

Advt The open offer has been triggered by Sanofi and CD&R entering into exclusive negotiations for the potential sale and purchase of a 50 per cent controlling stake in Opella, Sanofi's consumer ...

Global investment firm CD&R on Monday announced an open offer to acquire a 26 per cent stake in Sanofi Consumer Healthcare India Ltd for an aggregate of up to Rs 2,983 crore. The development follows ...

The proposed transaction would see the French pharmaceutical company sell a controlling 50% stake in Opella--home to brands such as Allegra, Dulcolax and IcyHot--to CD&R, French state-owned ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton ...